Literature DB >> 23617285

Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.

C Herbert1, W Kwa, S Nakano, K James, V Moiseenko, J Wu, D Schellenberg, M Liu.   

Abstract

Stereotactic body radiotherapy (SBRT) is a treatment option for patients with early stage lung cancer. Treatment duration can be >30 minutes per fraction with non-coplanar 3D-conformal radiotherapy (3D-CRT). Whilst this is generally well tolerated, faster delivery techniques are desirable. Volumetric modulated arc therapy (VMAT) allows for fast delivery of radiation treatment. The purpose of this planning study was to compare SBRT with 3D-CRT and VMAT, with VMAT plans generated using both single arc and 3 non-coplanar partial arcs. Ten patients who previously underwent SBRT (48 Gy in 4 fractions) with 3D-CRT were selected. VMAT plans were generated to treat the PTV while limiting doses to organs at risk. Cumulative dose volume histogram (DVH) parameters were compared between the 3 techniques using the Wilcoxon matched pairs test. Treatment delivery time was also assessed. Both VMAT techniques covered target volumes more conformally than 3D-CRT with a mean V48/VPTV of 1.21 for 3D-CRT, 1.03 for 3 arc plans and 1.01 for single arc plans (p = 0.005). Dose constraints to organs at risk were met using all three techniques. Mean lung doses were 2.93 Gy for 3D-CRT, 2.87 Gy for single arc and 2.73 Gy for the 3 arc technique (3-arc vs. 3D-CRT: p = 0.009). Lung V20 for 3D-CRT, 1 arc and 3 arcs were 3.24%, 2.89% and 2.73%, respectively (3 arc vs. 3D-CRT: p = 0.028). Mean time to deliver a single fraction was 13 minutes for 3D-CRT, 9.2 minutes for 3 arcs and 5.5 minutes for 1 arc. VMAT resulted in improved conformality compared to 3D-CRT. The 3 arc technique appears to have the lowest dose to lung although the magnitude is unlikely to be clinically significant. The main advantage of VMAT over 3D-CRT is faster treatment delivery time. Shortened treatment times are anticipated to improve tolerability of this treatment and reduce the chance of error due to intra-fraction motion.

Entities:  

Mesh:

Year:  2013        PMID: 23617285     DOI: 10.7785/tcrt.2012.500338

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  9 in total

Review 1.  Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions.

Authors:  Timothy A Lin; Jessica S Lin; Timothy Wagner; Ngoc Pham
Journal:  J Gastrointest Oncol       Date:  2018-10

2.  Interfractional diaphragm changes during breath-holding in stereotactic body radiotherapy for liver cancer.

Authors:  Daisuke Kawahara; Shuichi Ozawa; Takeo Nakashima; Shintaro Tsuda; Yusuke Ochi; Takuro Okumura; Hirokazu Masuda; Kazunari Hioki; Tathsuhiko Suzuki; Yoshimi Ohno; Tomoki Kimura; Yuji Murakami; Yasushi Nagata
Journal:  Rep Pract Oncol Radiother       Date:  2018-02-10

3.  Three-dimensional conformal radiotherapy by delineations on CT-based simulation in different respiratory phases for the treatment of senile patients with non-small cell lung cancer.

Authors:  Weifeng Wang; Feng Yuan; Guoping Wang; Zhiren Lin; Yanling Pan; Longhua Chen
Journal:  Onco Targets Ther       Date:  2015-09-07       Impact factor: 4.147

4.  Dynamic simulation of motion effects in IMAT lung SBRT.

Authors:  Wei Zou; Lingshu Yin; Jiajian Shen; Michael N Corradetti; Maura Kirk; Reshma Munbodh; Penny Fang; Salma K Jabbour; Charles B Simone; Ning J Yue; Ramesh Rengan; Boon-Keng Kevin Teo
Journal:  Radiat Oncol       Date:  2014-11-01       Impact factor: 3.481

5.  Dosimetric comparison of coplanar and noncoplanar beam arrangements for radiotherapy of patients with lung cancer: A meta-analysis.

Authors:  Min Ma; Wenting Ren; Minghui Li; Chuanmeng Niu; Jianrong Dai
Journal:  J Appl Clin Med Phys       Date:  2021-02-26       Impact factor: 2.102

6.  Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non-small cell lung cancer.

Authors:  Seong Soon Jang; Yohan Shin; Suk Young Park; Gil Ja Huh; Young Jun Yang
Journal:  Thorac Cancer       Date:  2021-10-24       Impact factor: 3.500

7.  Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery.

Authors:  Kimmen Quan; Karen M Xu; Ron Lalonde; Zachary D Horne; Mark E Bernard; Chuck McCoy; David A Clump; Steven A Burton; Dwight E Heron
Journal:  Front Oncol       Date:  2015-10-06       Impact factor: 6.244

8.  Monitor unit optimization in stereotactic body radiotherapy for small peripheral non-small cell lung cancer patients.

Authors:  Bao-Tian Huang; Zhu Lin; Pei-Xian Lin; Jia-Yang Lu; Chuang-Zhen Chen
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

9.  Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer.

Authors:  Michael Mix; Sean Tanny; Tamara Nsouli; Ryan Alden; Rishabh Chaudhari; Russell Kincaid; Paula F Rosenbaum; Jeffrey A Bogart; Paul Aridgides
Journal:  Lung Cancer (Auckl)       Date:  2019-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.